AN address of this kind affords an opportunity-of dealing with some general survey, and is, I think, intended to reflect some kind of personal outlook. Briefly, I was attracted to the subject I have chosen in the following-way. I was working simultaneously at the action of snake venoms and of saponins, and was struck by the remarkable resemblance between their actions. Without going into details of the differences in action of different venoms and different saponins I may mention the following general points of resemblance. Both venoms and saponins have a large molecule, diminish surface tension, cause a very permanent lather when shaken in solution,. heemolyse blood-corpuscles, are not toxic when taken by mouth-as compared with subcutaneous or intravenous injection-produce cedema at the point of injection, cause distal haemorrhages in serous membranes, arrest the perfused frog's heart in systole and arrest the respiration in mammals.
A very brief consideration of such syndromes will lead to the conclusion that they fall into at least two categories. It is now so well known that it forms part of the elementary instruction in pharmacology, that a large number of substances, so far apart chemically, for example, as ipecacuanha, tartar emetic, senega, squill, and ammonium carbonate, though they differ in other respects pharmacologically, when given by mouth all produce one group of actions: emesis, increased salivary secretion, increased bronchial secretion, and increased sweat secretion. It is now recognized that those four effects are due to one physiological mechanism: they are reflexes provoked by irritation of the upper part of the alimentary canal. Any substance which produces nausea will produce these effects more or less. The reason why only some of these gastric irritants are of practical therapeutic value is that, to produce a useful expectorant action for example, an optimum gastric irritation is necessary; it must be sufficiently prolonged to produce a continued bronchial secretion, but not so violent as to cause subsequent gastritis. Though this association of symptoms is now well known it can hardly be described as obvious seeing that its recognition required centuries. So far as I can find, Christison was the first to come near the present explanation of the expectorant action of ipecacuanha when he wrote, " the pulmonary mucous membrane would seem to be often stimulated to increased secretion by repeated small doses, although nausea be not produced, probably in consequence of the lungs sympathizing with a gentle stimulus and increased secretion of the gastric mucous membrane."
The syndrome of gastric irritation with increased salivary, bronchial and sweat secretion, a group of actions which is produced by a variety of substances having nothing chemically in common, is caused by a common and explainable physiological mechanism and may for this reason be called a " homogeneous syndrome."
There is, however, another type of syndrome which is more difficult but which may some day prove to be of greater scientific importance. The resemblances, for example, between the actions of harmaline and quinine cannot at present be related to known physiological or biochemical facts. Assuming that these similarities in action are not due to similarities in chemical constitution, and assuming that they have some reality-(and the fact that, in this and other cases, one can predict actions which are verified by subsequent experiment, leads to the belief that they have)-then one is here dealing with a syndrome for which no common physiological basis can yet be found; and perhaps for cases of this kind the term ' heterogeneous syndrome " might be convenient. I propose to make a few observations on both types of syndrome.
(1) Homogeneous Syndromes.
The recognition of these is part of the stock in trade of pharmacology. Some are fairly obvious, some have required extended research for their recognition. The gradual increase in knowledge of the site of action of drugs which influence smooth muscle is a familiar example.
It was a fairly easy step-though at first, apparently, not exactly obvious, to discover that a substance which stimulated smooth muscle in one organ would tend to do so in another. Thus barium was soon recognized as an almost universal stimulant of smooth muscle. But the actions of adrenalin presented a confused series of unconnected data until it was discovered that its action was to stimulate sympathetic nerve-endings. Its actions on the eye, heart, bronchi, gut, uterus, etc.actions which varied qualitatively in different organs and even in the same organ in different animals--'immediately fell into line with the effects of sympathetic stimulation.
Further research showed that many other amines produced the same group actions, and to connote this group action, Barger and Dale, whose work has done so much to illuminate this region of pharmacology, invented the term " sympathomimetic." Though even its creators would hardly anticipate for this word a brilliant poetical career, the necessity for the term has been justified by its subsequent usefulness. It seemed to me that perhaps a generic expression for group actions, of which sympathomimetic action is one example, might also be useful, and the term "homogeneous syndrome " was the best I could think of.
With the parallel advance of physiology and pharmacology, an increasing number of homogeneous syndromes have become recognized. One need only mention thatstill keeping to actions on smooth muscle-we speak of a " muscarine" action, an " atropine" action, a "nicotine" action. It would be unwise to suppose that we have reached finality in the recognition and explanation of such syndromes. In ergotoxine, for example, Dale discovered a new and remarkable -syndrome, and in the process of time others will be discovered. I wish to discuss one or two which I think may not be so familiar and of which I have had personal experience.
The first is a group of symptoms, which are often seen in the frog, and which one might not at first think of associating or of ascribing to a common physiological mechanism. The symptoms are partial paralysis of the voluntary muscles, rise of the lower eyelids, and arrest of the lymph hearts. This is a syndrome which is due to paralysis of the nerve-endings in voluntary muscle and is typical of the action of curare and of substances that act like it. The early stage of curare paralysis is characterized by early fatigue of the voluntary muscles. The lower eyelid in the frog is depressed by a muscular effort and rises so as to cover the eye when the muscle is paralysed. The lymph hearts, as was first shown, I think, by Bernard, belong physiologically to the system of voluntary muscle, and are acted on by drugs which influence voluntary muscle rather than by those which influence ordinary cardiac muscle. The reason, I imagine, why these two structures show curariform paralysis early is that they are in continual activity and therefore show early fatigue. The same symptoms occur with cobra venom, which also paralyses nerve-endings in voluntary muscle, and I remember that when I was carrying out experiments on cobra venom, the rise of the lower eyelids-a symptom which could be seen yards away--was of great assistance, as it at once revealed whether the frog had received a physiologically active dose of venom. This group of symptoms: partial paralysis of mobility, rise of the lower eyelid, arrest of lymph hearts, are the result therefore of one explainable physiological action, namely, paralysis of nerve-endings, and may be regarded as a homogeneous syndrome which is useful for diagnosing the site of action of curare-like substances. Diagnosis by such syndromes is, of course, especially useful in giving a clue to the site of action of drugs of which there is only a limited quantity available for pharmacological investigation. The sequence of symptoms resulting from descending paralysis of the central nervous system in the frog may perhaps be regarded as a homogeneous syndrome. This sequence, as displayed by the actions of morphine, anesthetics and many chemically unrelated substances, is very similar and resembles, closely the effects of destruction of the central nervous system at progressively lower levels. Many years ago I found an undescribed link in this chain. In experiments with yohimbine I found that it produced, after a previous stimulation, a descending paralysis of the central nervous system of the frog. At one stage of this paralysis there appeared a reflex which I described as a fly-catching reflex. The frog would snap with extension of the tongue when the nose or fore-limb was touched, or sometimes even if a bright light was suddenly turned on the animal. A normal frog never does this and the symptom had not been described as the result of drug action. However, a similar reflex had been described as a result of such a removal of the brain of the frog as would correspond to the area paralysed by yohimbin, at the time that the reflex appears. If this explanation was correct, that this reflex was one link in the chain of symptoms of descending paralysis, then it might also appear in the course of the paralysis produced by other depressants. Several years later I made some experiments, which hardly seemed worth mentioning, with the confident anticipation of finding this reflex appear under the action of other cerebral depressants. I found that it did occur, for example, with chloroform and ether, but was very evanescent and usually more easily elicitable when the animal is recovering from the effects of an anesthetic. The reason why this reflex is difficult to miss with yohimbine and difficult to hit with chloroform or ether is probably that in the first case the descending paralysis is long drawn out so that separate stages can 'be recognized; whereas with the anesthetics the paralysis passes from one area to another more quickly, so the symptoms of any one stage may easily be missed.
This chain of symptoms in the frog, occurring with a large number of chemically unrelated drugs which produce a descending paralysis of the central nervous system, may therefore be regarded as a kind of homogeneous syndrome. The discovery of a new link in this chain, occurring with one of these drugs, may lead to the verified prediction that it will occur with other drugs presenting the rest of the syndrome, and the more complete is the knowledge of the syndrome in question the more accurate is the localization of the site of the paralysis.
A study of group actions is not only of value in localizing the site of action of a drug and of associating drugs, but is of recognized value in differentiating them. I may mention one or two examples from my own experience.
Among the complicated actions of viperine venoms are the following:-They cause: (1) cedema and hemorrhage at the point of injection;
(2) intravascular clotting;
(3) distal haomorrhages in serous membrane, etc., the site of which varies in different species of animals. At one time the hamorrhages were regarded as a result of intravascular clotting. Sir Thomas Fraser and I disproved this clearly in one case. We found that echis venom had a remarkable effect in causing edema and hemorrhages, but had little effect, compared with other venoms, in causing intravascular clotting. A more direct proof was afforded by the following experiment.
When the blood-vessels of the frog were perfused with solutionls of echis venom in Ringer's solution, the animal became completely waterlogged. Fluid finds its way into the serous cavities, under the skin, between the muscles; and the animal may double its weight by perfusion for a very short time. In this case there can be no question of the escape of fluid from the vessels being primarily due to intravascular clotting, for the vessels were perfused with Ringer's solution until the blood was removed from the vessels, before the venom solution was turned on. What is more remarkable, and, so far as I know, is an effect which has not been described with any other substance, is that when the frog's heart is perfused, using Schafer's perfusion apparatus, the venom makes the heart wall permeahle. In these experiments the heart is tied on to a two-way canula by a ligature round the auricular groove, and a mixture of Ringer's solution and ox-blood corpuscles is used as the perfusing solution. In a normal heart thus perfused there is no escape of blood through the ventricular wall. But when echis venom is added, the blood soon trickles, and finally pours, through.
From this series of experiments we drew the following conclusions: The cedema, at the site of injection, the distal haemorrhages, the cedema in the perfused frog, the permeability of the ventricle wall in the perfused heart, may be explained by a rupture or solution of the endothelium of capillaries or of the corresponding lacunce in the ventricle wall. From the facts that, in the case of distal haemorrhages occurring in the intact animal, unaltered (unhaemolysed) corpuscles appeared, for example, in the rectum of the rabbit, and were exuded from the conjunctiva in rats, and that ox corpuscles passed unchanged through the ventricle of the frog, we concluded that there was an actual rupture of the vascular endothelium. In the terms I am using this may provisionally, at any rate, be regarded as a homogeneous syndrome-a series of symptoms with a common physiological basis-which might be used as a test of identity in the case of other substances.
When Dare elucidated the action of histamine on the capillaries I did a few perfusions of the frog's heart by Schafer's apparatus with different concentrations of histamine. Histamine did not render the heart wall permeable. From these experiments one could deduce that the vascular actions of echis venom and histamine are certainly not identical; perhaps also they afford some evidence in favour of the view that histamine does not cause actual rupture of the capillaries, but, as Dale interprets it, causes a dilatation of the wall with increased permeability to fluids.
Recognition of a syndrome of this kind is therefore of importance in two directions. In the first place, though, so far as I know, no substances other than snake venom have as yet been discovered to produce this particular syndrome resulting from a toxic action on vascular endothelium, it is highly probable that such substances will be discovered. Secondly, such a syndrome can be used as a physiological test for identity of action, as for example, to separate the capillary action of histamine from that of echis venom.
While an enormous advance has been made in the recognition of homogeneous syndromes, plenty of difficulties remain. It is still impossible in the present state of knowledge to correlate pharmacological action completely with physiological knowledge. Many examples of this will occur to you, but I should like to take one example in which I have been interested recently.
In regard to the sympathomimetic drugs, various quantitative differences have been observed in amines which resemble adrenaline in action. The most interesting deviation from adrenaline has been ergotoxine. Dale has explained the actions of ergotoxine as due to a stimulation of sympathetic terminations only when those are motor, and by paralysis of those motor terminations with larger doses of ergotoxine. It is a new type of syndrome. But it is not so homogeneous as the action of adrenaline.
Some years ago I wished, for a certain purpose, to paralyse the motor sympathetics in the mammalian heart. Before ergotoxine was discovered there was no really convenient substance for this purpose, but now one was available. When I perfused the heart with ergotoxine I found that in the cat, rabbit and frog ergotoxine did not produce any sign of sympathetic stimulation, nor could I abolish the action of adrenaline by prolonged perfusion with ergotoxine. I found that both Dale and Wiggers had had much the same experience.
It is rather remarkable that ergotoxine should leave out the cardiac sympathetic terminations, especially when it acts on the vessels. This would seem to be a typical example of an exact coincidence of pharmacological action with physiological action breaking down. But in this and other instances there is little doubt than an explanation will be forthcoming, only here it would seem to lie rather with the physiological side.
Ephedrine, a very near neighbour of adrenaline, the actions of which have been more recently decribed, seems to differ from adrenaline somewhat in the same way as does ergotoxine, but in the opposite direction in so far as it appears to stimulate the motor sympathetics of the heart more than the vasoconstrictors. This may be due to a subsidiary action but, if not, it would rather suggest the possibility that, in reaction to drugs, the motor sympathetics of the heart do not always fall in, quantitatively at least, with the motor sympathetics elsewhere. Indeed, just as a closer investigation of typhoid led to the separation of what was once regarded as a single disease into three definite and separate-though similar-diseases, so a closer investigation of more drugs may lead eventually to the separation of what we would now regard as a homogeneous syndrome due to stimulation of motor sympathetic terminations into two or more separate and definite-though similar syndromes, of which some drugs would follow one, other drugs another.
Another and similar type of discrepancy arises in connexion with the direct stimulant action of drugs on involuntary muscle. There are so many histological and functional differences between involuntary muscle in different organs that it is not surprising that a drug should act quantitatively-or even qualitatively-differently on different organs. For example, one would not expect cardiac, uterine, and bronchial muscle necessarily to respond in the same way.
Possibly as a type of stimulant of involuntary muscle, barium has been ratber misleading. Barium chloride is a very simple substance, and it might be anticipated that the physiochemical reaction which underlies the muscle stimulation produced by it would be a reaction of not very specialized type, such as would occur more or less in any involuntary muscle. But as more and more drugs have been investigated, especially those which have themselves a complicated structure, it has become increasingly clear that one cannot regard smooth muscle in different organs as being sufficiently alike to give an identical reaction to drugs. I need only mention such an example as that histamine relaxes the uterus in the rat, while it stimulates the uterus in other animals, a difference not seen with pituitary. Pituitary is said to have no action on the vas deferens and little or none on the bronchi, though it stimulates most smooth muscle. Nitrites dilate the blood-vessels generally, but, according to Macht, contract the pulmonary artery. So far it has not been possible to correlate these pharmacological differences with developmental, structural or chemical difference in different kinds of smooth muscle. Failing that, it may be found that smooth muscle can be divided into subsidiary groups, of which some drugs may act on one group, others on another; that there may be subsidiary syndromes, displayed by smooth muscles.
Heterogeneous Syndromes. When we come to what I have ventured to call heterogeneous syndromes we enter upon an almost unknown territory. Some might deny that there is a terra firma at all. The possibilities and alternative explanations may be outlined by a simple example. There seems to be a very constant association of an antipyretic and an analgesic action in the case of a large number of artificial antipyretics. There are several possible explanations of this. It may be an obscure example of similarity of pharmacological action due to similarity in chemical constitution of the drugs in question. It may be an obscure example of a homogeneous syndrome, as, for example, the relief of pain being due to alterations in the circulation resulting from the antipyretic action. Or thirdly, it may be that, to put it crudely, there is some chemical similarity between the pain centre and the heat-regulating centre whereby drugs, not necessarily of similar constitution, if they attack one centre, will be likely to attack the other. Probably, in any case, other instances of all three types of heterogeneous syndrome exist. However, it is the third type which would perhaps be most interesting. Is there any evidence of " trends " in selective action, of the type that substances of dissimilar chemical structure will preferentially attack dissimilar physiological tissues ? Section of Therapeutics and Pharmacology 7 Perhaps the following is one of the least equivocal examples. Nicotine in small doses stimulates all autonomic nerve ganglia-a homogeneous syndrome; it also stimulates the nerve-ends in voluntary muscle-a second homogeneous syndrome.
But curare acts on both these structures in the opposite direction and antagonizes the two group actions of nicotine. As this dual action of nicotine and curare on two dissimilar physiological structures cannot be explained by any chemical similarity between the two drugs, it would seem to imply some chemical or physical siimilarity between the autonomic nerve ganglia and the nerve-ends in voluntary muscle. There is a similar association between the autonomic ganglia and the parasympathetic nerve-ends, as Burn and Dale have emphasized in their study of the action of quaternary ammonium bases. In regard to these three sites of action, Dale has pointed out that " we can merely conclude that there is some dogree of biochemical similarity between the ganglion cells of the whole involuntary nervous system, and the terminations of voluntary nerve-fibres in striated muscle, on the one hand, and the mechanism connected with the peripheral terminations of the cranio-sacral involuntary nerves on the other. We have a whole group of substances which affect both." This is one type of heterogeneous syndrome-a group of actions which tend to run together, but are not the result of a common physiological mechanism. I feel confident of an increasing recognition of heterogeneous syndromes with the rapid advances of pharmacology.
Throughout this paper I have had subsidiarily in view another problem. I have always hoped that a study of syndromes may prove to be one avenue of approach to the most difficult and fundamental problem in pharmacology, namely:,. why does a drug act on a particular tissue ? Why, for example, does adrenaline attack the sympathetic terminations or apomorphine the vomiting centre ? Although attempts have been made to provide a physical or chemical explanation for the action of some drugs, it will be agreed that our ignorance of the subject is almost complete. We have not even begun to understand why a physico-chemical change should in one case produce stimulation and in another paralysis. Some a,lvance has been made in explaining simpler problems. For example, an explanation can be given of the astringent action of tannic acid as being due to the coagulation of proteins, or of the haemolytic action of saponins as due to the solvent action on the lipoids of the cell envelope, and so on. Every pharmacologist would, however, agree as to how seldom any chemical action reveals itself which could be applicable to solving these problems. In an experience of over twenty years of pharmacology I can only recall one instance which struck me as having definite possibilities in this direction. In experiments with one of the snake venoms I found that, coincidently with the onset of the usual toxic symptoms, there occurred an opacity of the surface of the lens of the eye. When the two lenses of the eye of a pithed frog were removed and placed in separate glasses, one in Locke's solution and the other in the same solution plus venom, a similar opacity appeared only in the lens exposed to venom. Here was a naked-eye physical or chemical reaction which was produced in the living body coincidently with the toxic actions and which could be duplicated in vitro. As the lens may be supposed to have a relatively simple or at least homogeneous structure, this certainly did just suggest the possibility that an explanation of the reaction between the lens and the venom might throw light on tho chemical action of the venom in general.
But recognizable chemical reactions with such concentrations of a drug as occur in the body are admittedly rare, and the problems of the chemical expllnation of the action of drugs may be otherwise solved. It is conceivable that a study of syndromes may help in the following ways. The problem may be solved by a direct attack. For example, a chemical explanation may be found for the action of N-THERAP. 2 * Gunn: President's Address: Pharmacological Syndromnes histamine on smooth muscle. When one considers, however, the extraordinary complicated chemistry of the tissues, when one recalls Professor Leathes' calculation that out of the known amino-acids many millions of different proteins could be constructed, the problem of a direct chemical attack is a formidable one. It may be, however-at least this has often occurred in the advance of science-that the problem will be more easily solved by a study of the exceptions. If, for example, it is a fact that the rat's uterus is insusceptible to the action of histamine, it might indicate (other explanations are possible) that there is some factor wanting in the uterus of the rat that is present in the uterus of other animals; and this factor might be more easily identified than a substance in the uterus with. which histamine combines.
The study of heterogeneous syndromes may afford a third line of attack. If, for example, we assume that, in the words of Dale, there is some biochemical affinity between the ganglion cells of the autonomic nervous system and the parasympathetic terminations, and also of the nerve endings in voluntary muscle, then possibly it might be easier to identify the common element than to determine directly what is the element in any of these structures with which physostigmine or curare combines, or which they alter.
Lastly, this study of heterogeneous syndromes appears to be essentially different from the usual attempt to correlate physiological action with chemical constitution. In the latter case one deals with a series of chemically related substances and determines whether they exert the same physiological actions, with a view to discovering a common chemical factor in the drugs employed. In the case of heterogeneous syndromes, one at least approaches the subject from another angle, though the problems are related. One is using a series of chemically unrelated substances and determining their common action on different tissues with a view to determining a common chemical factor in the various tissues actedupon. This is an almost unexplored field.
